FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Hospira Inc, Lake Forest Hydromorphone Hydrochloride Injection Recall

Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Single Dose…

HOSPIRA INC, LAKE FOREST · LAKE FOREST, IL

Risk level
Class II
Reported by FDA
Aug 16, 2017
Recall ID
D-1080-2017
Check your lot numberHow we source this data

Summary

Hospira Inc, Lake Forest recalled Hydromorphone Hydrochloride Injection starting Jul 26, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1080-2017 on Aug 16, 2017. Reason: Presence of Particulate Matter: Silicone oil. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: Silicone oil

Product description

Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Single Dose Vial. Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618 USA. NDC: 0703-0018-01

Lot numbers, UPCs & expiration codes

Lot #: 560053F, Exp. 01AUG2017

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1080-2017
Classification
Class II
Status
Terminated
Recall initiated
Jul 26, 2017
FDA report date
Aug 16, 2017
Quantity
14,300 vials
Recall type
Voluntary: Firm initiated
Recalling firm
HOSPIRA INC, LAKE FOREST

Original FDA data

Every field from FDA enforcement report D-1080-2017, exactly as published.

Show all FDA fields
City
LAKE FOREST
State
IL
Status
Terminated
Country
United States
Event ID
77836
Address
275 NORTH FOREST DRIVE
Code information
Lot #: 560053F, Exp. 01AUG2017
Postal code
60045
Report date
Aug 16, 2017
Product type
Drugs
Recall number
D-1080-2017
Classification
Class II
Recalling firm
HOSPIRA INC, LAKE FOREST
Product quantity
14,300 vials
Termination date
May 11, 2018
Reason for recall
Presence of Particulate Matter: Silicone oil
Voluntary / mandated
Voluntary: Firm initiated
Product description
Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Single Dose Vial. Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618 USA. NDC: 0703-0018-01
Distribution pattern
Nationwide in the USA
Recall initiation date
Jul 26, 2017
Initial firm notification
Telephone
Center classification date
Aug 9, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1080-2017, published Aug 16, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls